Skip to main content

Anastomosis, Functional

0
Pipeline Programs
2
Companies
2
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

GT Metabolic Solutions
GT Metabolic SolutionsMN - St. Michael
1 program
Magnet SystemN/A2 trials
Active Trials
NCT07609511Recruiting10Est. Feb 2027
NCT07431723Recruiting50Est. Feb 2028
GT Biopharma
GT BiopharmaSAN FRANCISCO, CA
1 program
Magnet SystemN/A

Trial Timeline

Clinical trial activity over time

2026
2027
2028
GT Metabolic SolutionsMagnet System
GT Metabolic SolutionsMagnet System

Clinical Trials (2)

Total enrollment: 60 patients across 2 trials

Magnet System Gastric Outlet Obstruction Study

Start: Sep 2026Est. completion: Feb 202710 patients
N/ARecruiting

Creation of Compression Anastomosis Using the GT Metabolic Magnet System

Start: Feb 2026Est. completion: Feb 202850 patients
N/ARecruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 actively recruiting trials targeting 60 patients
2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.